RxDoctor Payments Data

Matthew Cox

Otology & Neurotology · Winter Park, FLNPI 1457643793

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 65 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 24.3% of the total. Reporting peaked in 2019 at $599 and has fallen 62.6% since, to $224 in 2025. That places this record below the midpoint for otology & neurotology clinicians in FL, where the typical reported total is $5,109.

$1,896in general payments, 2019–2025

Across 65 payments — averaging $29.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$460
  • Acclarent, Inc$259
  • Sanofi$223
  • Cochlear Americas$141
  • Genentech USA, Inc.$125
  • Stryker$119
  • plus $569 from 12 others

What the payments were for

  • Food & beverage$1,896100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,896 in reported general payments places this provider in the 35th percentile of 25 otology & neurotology providers in Florida.

See all otology & neurotology providers in Florida

Medicare billing

Part B allowed, 2024
$212,127
Medicare patients
481
Services billed
2,212

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl310$9,273
Ipratropium Bromide226$5,556
Ofloxacin159$3,168
Fluticasone Propionate187$2,779
Epinephrine13$2,701
Levocetirizine Dihydrochloride163$1,723
Prednisone135$1,229
Ondansetron OdtOndansetron70$658
Triamcinolone Acetonide51$461
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen63$447
Ciprofloxacin Hcl49$429
Montelukast Sodium45$384
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav38$373
Cephalexin31$273
Mupirocin39$253

Paid to pharmacies, not to this prescriber.

Other otology & neurotology in Winter Park

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →